INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 121 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,419 | -82.9% | 59,000 | -87.0% | 0.00% | – |
| Q1 2023 | $72,527 | +132.9% | 453,296 | +708.0% | 0.00% | – |
| Q4 2022 | $31,136 | -60.1% | 56,100 | -14.2% | 0.00% | – |
| Q3 2022 | $78,000 | -74.9% | 65,400 | -86.7% | 0.00% | – |
| Q2 2022 | $311,000 | +70.9% | 490,701 | +206.5% | 0.00% | – |
| Q1 2022 | $182,000 | -73.0% | 160,105 | -46.5% | 0.00% | – |
| Q4 2021 | $673,000 | -49.7% | 299,504 | -23.5% | 0.00% | – |
| Q3 2021 | $1,339,000 | +91.8% | 391,267 | +67.5% | 0.00% | – |
| Q2 2021 | $698,000 | -60.0% | 233,647 | -56.8% | 0.00% | – |
| Q1 2021 | $1,745,000 | +2626.6% | 540,312 | +1689.1% | 0.00% | – |
| Q4 2020 | $64,000 | +357.1% | 30,200 | +86.8% | 0.00% | – |
| Q1 2020 | $14,000 | -68.2% | 16,165 | -64.4% | 0.00% | – |
| Q4 2019 | $44,000 | +57.1% | 45,384 | +65.4% | 0.00% | – |
| Q3 2019 | $28,000 | -48.1% | 27,434 | -8.5% | 0.00% | – |
| Q2 2019 | $54,000 | -59.4% | 29,991 | -57.8% | 0.00% | – |
| Q1 2019 | $133,000 | +3.9% | 70,985 | -34.3% | 0.00% | – |
| Q4 2018 | $128,000 | -39.9% | 108,087 | +37.2% | 0.00% | – |
| Q3 2018 | $213,000 | +55.5% | 78,778 | +9.6% | 0.00% | – |
| Q2 2018 | $137,000 | +18.1% | 71,900 | +30.2% | 0.00% | – |
| Q1 2018 | $116,000 | +96.6% | 55,211 | +89.3% | 0.00% | – |
| Q4 2017 | $59,000 | +321.4% | 29,171 | +175.5% | 0.00% | – |
| Q3 2017 | $14,000 | -48.1% | 10,590 | -38.4% | 0.00% | – |
| Q2 2017 | $27,000 | -90.3% | 17,204 | -80.1% | 0.00% | – |
| Q1 2017 | $279,000 | +548.8% | 86,522 | +169.2% | 0.00% | – |
| Q4 2016 | $43,000 | 0.0% | 32,144 | +18.0% | 0.00% | – |
| Q3 2016 | $43,000 | -87.0% | 27,251 | -30.3% | 0.00% | – |
| Q3 2015 | $330,000 | -95.6% | 39,100 | -92.6% | 0.00% | -100.0% |
| Q1 2015 | $7,428,000 | -1.9% | 531,294 | +18.5% | 0.01% | 0.0% |
| Q4 2014 | $7,571,000 | +1673.1% | 448,247 | +1307.3% | 0.01% | – |
| Q3 2014 | $427,000 | -3.2% | 31,852 | -0.3% | 0.00% | -100.0% |
| Q4 2013 | $441,000 | -88.7% | 31,941 | -85.7% | 0.00% | -83.3% |
| Q3 2013 | $3,888,000 | +257.7% | 222,801 | +233.0% | 0.01% | +200.0% |
| Q2 2013 | $1,087,000 | – | 66,914 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,575,000 | $21,237,000 | 2.26% |
| AIGH Capital Management LLC | 1,650,256 | $5,330,000 | 1.12% |
| BVF INC/IL | 8,383,645 | $27,079,000 | 1.02% |
| GUARDIAN POINT CAPITAL, LP | 1,200,000 | $3,876,000 | 0.97% |
| Tri Locum Partners LP | 1,210,863 | $3,911,000 | 0.97% |
| Altium Capital Management LP | 972,327 | $3,141,000 | 0.87% |
| Worth Venture Partners, LLC | 387,141 | $1,250,000 | 0.61% |
| DAFNA Capital Management LLC | 459,260 | $1,483,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 530,000 | $1,712,000 | 0.33% |
| KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 173,110 | $559,000 | 0.24% |